THERESA HEGGIE, a director at $BCRX, sold 70,000 shares of the company on 08-13-2025 for an estimated $595,868. We received data on the trade from a recent SEC filing. This was a sale of approximately 51.7% of their shares of this class of stock. Following this trade, they now own 65,352 shares of this class of $BCRX stock.
$BCRX Insider Trading Activity
$BCRX insiders have traded $BCRX stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BCRX stock by insiders over the last 6 months:
- THERESA HEGGIE sold 70,000 shares for an estimated $595,868
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BCRX Hedge Fund Activity
We have seen 167 institutional investors add shares of $BCRX stock to their portfolio, and 121 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AVORO CAPITAL ADVISORS LLC removed 4,200,000 shares (-48.3%) from their portfolio in Q2 2025, for an estimated $37,632,000
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 4,084,403 shares (+2103.7%) to their portfolio in Q2 2025, for an estimated $36,596,250
- ASSENAGON ASSET MANAGEMENT S.A. added 3,606,566 shares (+25631.2%) to their portfolio in Q2 2025, for an estimated $32,314,831
- UBS GROUP AG added 3,211,465 shares (+133.6%) to their portfolio in Q2 2025, for an estimated $28,774,726
- DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) removed 2,954,777 shares (-36.3%) from their portfolio in Q1 2025, for an estimated $22,160,827
- CALIGAN PARTNERS LP removed 2,468,761 shares (-79.4%) from their portfolio in Q2 2025, for an estimated $22,120,098
- WALLEYE CAPITAL LLC added 2,145,936 shares (+1387.2%) to their portfolio in Q2 2025, for an estimated $19,227,586
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BCRX Analyst Ratings
Wall Street analysts have issued reports on $BCRX in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 08/04/2025
- B of A Securities issued a "Buy" rating on 07/01/2025
- Wedbush issued a "Outperform" rating on 06/30/2025
- RBC Capital issued a "Outperform" rating on 06/30/2025
- JP Morgan issued a "Overweight" rating on 05/06/2025
- HC Wainwright & Co. issued a "Buy" rating on 05/06/2025
- Cantor Fitzgerald issued a "Overweight" rating on 04/29/2025
To track analyst ratings and price targets for $BCRX, check out Quiver Quantitative's $BCRX forecast page.
$BCRX Price Targets
Multiple analysts have issued price targets for $BCRX recently. We have seen 9 analysts offer price targets for $BCRX in the last 6 months, with a median target of $17.0.
Here are some recent targets:
- Serge Belanger from Needham set a target price of $17.0 on 08/04/2025
- Tazeen Ahmad from B of A Securities set a target price of $15.0 on 07/01/2025
- Laura Chico from Wedbush set a target price of $18.0 on 06/30/2025
- Brian Abrahams from RBC Capital set a target price of $13.0 on 06/30/2025
- Gena Wang from Barclays set a target price of $11.0 on 05/07/2025
- Andrew Fein from HC Wainwright & Co. set a target price of $30.0 on 05/06/2025
- Jessica Fye from JP Morgan set a target price of $13.0 on 05/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
